Esperion Therapeutics, Inc is a biotechnology business based in the US. Esperion Therapeutics shares (ESPR) are listed on the NASDAQ and all prices are listed in US Dollars. Esperion Therapeutics employs 479 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Esperion Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ESPR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Esperion Therapeutics stock price (NASDAQ: ESPR)Use our graph to track the performance of ESPR stocks over time.
Esperion Therapeutics shares at a glance
|Latest market close||$19.91|
|52-week range||$16.77 - $41.77|
|50-day moving average||$21.48|
|200-day moving average||$25.94|
|Wall St. target price||$49.27|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.86|
Buy Esperion Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Esperion Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Esperion Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-15.92%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Esperion Therapeutics financials
|Revenue TTM||$233.7 million|
|Gross profit TTM||$78.2 million|
|Return on assets TTM||-31.77%|
|Return on equity TTM||-260.79%|
|Market capitalisation||$473.3 million|
TTM: trailing 12 months
Shorting Esperion Therapeutics shares
There are currently 9.0 million Esperion Therapeutics shares held short by investors – that's known as Esperion Therapeutics's "short interest". This figure is 0.9% up from 8.9 million last month.
There are a few different ways that this level of interest in shorting Esperion Therapeutics shares can be evaluated.
Esperion Therapeutics's "short interest ratio" (SIR)
Esperion Therapeutics's "short interest ratio" (SIR) is the quantity of Esperion Therapeutics shares currently shorted divided by the average quantity of Esperion Therapeutics shares traded daily (recently around 480208.82509304). Esperion Therapeutics's SIR currently stands at 18.81. In other words for every 100,000 Esperion Therapeutics shares traded daily on the market, roughly 18810 shares are currently held short.
However Esperion Therapeutics's short interest can also be evaluated against the total number of Esperion Therapeutics shares, or, against the total number of tradable Esperion Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Esperion Therapeutics's short interest could be expressed as 0.32% of the outstanding shares (for every 100,000 Esperion Therapeutics shares in existence, roughly 320 shares are currently held short) or 0.345% of the tradable shares (for every 100,000 tradable Esperion Therapeutics shares, roughly 345 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Esperion Therapeutics.
Find out more about how you can short Esperion Therapeutics stock.
Esperion Therapeutics share dividends
We're not expecting Esperion Therapeutics to pay a dividend over the next 12 months.
Have Esperion Therapeutics's shares ever split?
Esperion Therapeutics's shares were split on a 1:6 basis on 10 June 2013. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Esperion Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Esperion Therapeutics shares which in turn could have impacted Esperion Therapeutics's share price.
Esperion Therapeutics share price volatility
Over the last 12 months, Esperion Therapeutics's shares have ranged in value from as little as $16.77 up to $41.77. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Esperion Therapeutics's is 1.1387. This would suggest that Esperion Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Esperion Therapeutics overview
Esperion Therapeutics, Inc. , a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. .
Stocks similar to Esperion Therapeutics
Esperion Therapeutics in the news
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
First Week of ESPR March 2022 Options Trading
Frequently asked questionsWhat percentage of Esperion Therapeutics is owned by insiders or institutions?
Currently 1.582% of Esperion Therapeutics shares are held by insiders and 108.233% by institutions. How many people work for Esperion Therapeutics?
Latest data suggests 479 work at Esperion Therapeutics. When does the fiscal year end for Esperion Therapeutics?
Esperion Therapeutics's fiscal year ends in December. Where is Esperion Therapeutics based?
Esperion Therapeutics's address is: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108 What is Esperion Therapeutics's ISIN number?
Esperion Therapeutics's international securities identification number is: US29664W1053 What is Esperion Therapeutics's CUSIP number?
Esperion Therapeutics's Committee on Uniform Securities Identification Procedures number is: 16934W106
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert